This yr’s European Antibiotic Consciousness Day (EAAD) focuses on the targets outlined within the 2023 Council Advice to step up efforts within the European Union (EU) towards antimicrobial resistance in a One Well being strategy. These suggestions formulate the 2023 purpose to cut back complete antibiotic consumption (group and hospital sectors mixed) by 20%, utilizing consumption knowledge from 2019 as baseline.
Consumption of antibiotics locally accounts for round 90% of the entire use. This implies, {that a} substantial and constant decline in using antibiotics on this sector might be key on the way in which in direction of reaching the set targets for 2030 which intention at stopping and lowering antimicrobial resistance total.
Through the first yr of the COVID-19 pandemic, knowledge from the European Union (EU)/European Financial Space (EEA) confirmed an unprecedented 18.5% lower in group consumption of antibiotics in 2020 in contrast with the 2019 baseline. This drop has been associated to using non-pharmaceutical interventions (e.g. bodily distancing or carrying of face masks) which decreased total unfold of pathogens, and to the truth that prescriptions of antibiotics have been affected by the disrupted entry to healthcare providers through the first yr of the pandemic.
Uncommon fluctuation between 2019 and 2022
Of their speedy communication revealed in Eurosurveillance on the event of EAAD and World AMR Consciousness Week, Ventura-Gabarró et al. current most up-to-date knowledge reported to the European Surveillance of Antimicrobial Consumption Community. They present that the noticed lower from 2020 didn’t final.
As a substitute, together with the gradual lifting of interventions throughout the EU/EEA, imply group consumption went up once more and elevated by 18.8% between 2021 and 2022 with no vital distinction from the pre-pandemic degree in 2019. This rebound in consumption of antibacterials for systemic use locally sector moved antibiotic consumption charges again in direction of the 2019 baseline worth.
The info offered by Ventura-Gabarró et al. present totally different patterns of antibiotic consumption throughout the EU/EEA nations. In 13 of 27 nations, group antibiotic consumption was greater in 2022 than in 2019, with a mean enhance of 8.4% amongst these 13 nations (vary: 0.6–26.9).
From 2020 to 2021, the EU/EEA total, as in 15 particular person nations (Austria, Denmark, Estonia, Iceland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Portugal, Romania, Slovenia, Spain and Sweden), noticed no or only a marginal (lower than +/−3%) change in antibiotic consumption locally. Between 2021 and 2022 pre-pandemic ranges of 2019 have been reached once more with a mean enhance of 20.5%.
The authors spotlight that “though the resurgence of each viral and bacterial respiratory tract infections through the latter a part of our examine interval may partly clarify this rebound in antibiotic consumption, the rise might additionally replicate a missed alternative to strengthen and reinforce prudent antibiotic use.” They conclude that “the COVID-19-pandemic had a considerable affect on group antibiotic consumption within the EU/EEA between 2020 and 2022. International locations exhibited totally different patterns of antibiotic consumption, underlining the significance of understanding every nation in its personal context. Additional examination into native prescribing and consumption behaviors for particular antibiotic teams can inform efficient stewardship interventions and produce the EU/EEA nearer to its antibiotic consumption targets for 2030.”
Supply:
European Centre for Illness Prevention and Management (ECDC)
Journal reference:
Ventura-Gabarró, C., et al. (2023) Rebound in group antibiotic consumption after the noticed lower through the COVID-19 pandemic, EU/EEA, 2022. Eurosurveillance. doi.org/10.2807/1560-7917.ES.2023.28.46.2300604.
